Shanghai Raas Blood Products Co.,Ltd.’s Net Profit Rose 28.6% in First Quarter of 2022

Shanghai Raas Blood Products Co.,Ltd. (上海莱士血液制品股份有限公司) (002252.SZ) reported a net profit of 546 million yuan in the first quarter of 2022, up 28.6% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, up 97.3% year-on-year.

At the end of the reporting period, it had 27.7 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 4.8%.